Abstract
Over 60% of drugs are derived from natural products—chemicals made by living organisms like bacteria, fungi, and plants. But identifying and characterizing biologically active molecules in the complex chemical brew these organisms make can be a painstaking, yearslong process. By combining genome mining with microcrystal electron diffraction (microED), scientists have found what might be a faster way to identify drugs from natural products. Researchers led by University of California, Los Angeles, chemical biologist Yi Tang and California Institute of Technology organic chemist Hosea M. Nelson developed the prospecting process ( Nat. Chem. Biol. 2021, DOI: 10.1038/s41589-021-00834-2 ). The researchers comb through the DNA sequence of an interesting organism, looking for genes that are known to make enzymes responsible for constructing biomolecules. They then insert those genes into a host that they can grow in the lab. This host churns out those enzymes and the natural product of interest. “It’s a
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.